Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma
Study Information
Alliance Study ID: NCCTG-N0275
NCT Study ID (ClinicalTrials.gov): NCT00060333
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Melanoma & Skin Cancers
Alliance Study Chair: Barbara A. Pockaj, MD
Status: COMPLETED
Study Description
This phase II trial is studying how well adjuvant radiation therapy works in treating patients who have undergone surgery for desmoplastic melanoma. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy after surgery may kill any tumor cells remaining after surgery.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information